Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
5
×
amgen
boston blog main
inclisiran
new york
new york blog main
new york top stories
regeneron pharmaceuticals
alnylam pharmaceuticals
biotech
boston top stories
cholesterol
national top stories
pcsk9 inhibitors
alirocumab
evolocumab
fda
pcsk9
praluent
repatha
rna interference
sanofi
the medicines co.
bempedoic acid
corticosteroids
data
deals
detroit
detroit blog main
detroit top stories
drugs
esperion therapeutics
evercore isi
ezetimibe
fluoroquinolones
heart attack
joseph swartz
ldl
What
cholesterol
5
×
drug
medicines
5
×
lowering
medco
fda
new
twice
aces
acquire
agreed
alnylam
announced
approved
based
big
billion
bringing
brings
cash
ceo
clears
closer
combo
company
compound
data
deal
esperion
esperion’s
evidence
filing
flexible
heart
inched
inclisiran
key
lasting
levels
long
Language
unset
Current search:
cholesterol
×
medicines
×
" national blog main "
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms